Drug intelligence / Profile preview

siRBBP6

Development stage
Preclinical
Lead developer
University of Pretoria
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intratumoral
01

Overview

siRBBP6 is a small interfering RNA (siRNA) designed to target and silence the expression of the retinoblastoma binding protein 6 (RBBP6) gene. RBBP6 is a multi-functional protein that is frequently overexpressed in various malignancies, including cervical cancer, where it is associated with cell proliferation and the regulation of apoptosis through the modulation of p53 and BCL-2. By utilizing RNA interference (RNAi) technology, siRBBP6 facilitates the degradation of RBBP6 mRNA, thereby reducing the levels of the RBBP6 protein within the cell. Preclinical research, notably conducted at the University of Pretoria, has investigated the role of siRBBP6 in sensitizing cervical cancer cells to chemotherapeutic agents like cisplatin. These studies suggest that RBBP6 expression is a critical factor in the apoptotic response and growth inhibition of cancer cells, and its knockdown can significantly alter the cellular response to DNA-damaging treatments.

Other names
RBBP6 siRNARBBP-6 siRNARBBP 6 siRNAsiRNA targeting RBBP6retinoblastoma binding protein 6 siRNA
02

Targets

RBBP6 (Retinoblastoma-binding protein 6)

Beyond the preview

Go deeper on siRBBP6.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on siRBBP6.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call